NCT06953180Recruiting
Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Epigenetics and Prevention of Non-communicable Diseases in Kazakhstan: a Personalized Approach and Biological Age Prediction
Source: ClinicalTrials.gov · Last updated 11 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 6720 (estimated)
- First submitted
- 31 Mar 2025
- Start date
- 3 Mar 2025
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- Asfendiyarov Kazakh National Medical University
- Diseases
- Chronic kidney disease, Obesity, Type 2 diabetes
- NCT number
- NCT06953180
What you commit to
- Study type: Observational
- Planned participants: 6720
- From 3 Mar 2025 to the primary completion date, 1 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Failure to provide informed consent or incomplete participation in data collection procedures.
Age
- Age less than 18 years old or over 69 years old.
Who the study is looking for
- Adults aged 18 to 69 years.
- Residents of 17 regions of Kazakhstan.
- Willingness to participate and provide informed consent.
Age in the registry: 18 years to 69 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Asfendiyarov Kazakh National Medical University Coordinator of this site? Confirm its status | Almaty | Kazakhstan | Recruiting |
Related publications
- Age-Metabolic Profile of Lower Serum Estradiol Among Women in Kazakhstan: A Large National Survey-Based Analytical Study.Int J Environ Res Public Health · 2026 · PMID 42512238
This page is information, not medical advice. Discuss any trial with your doctor.